Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017940HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017748HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017597HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017749HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017535HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10007020HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018524HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017941HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017630HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017942HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807